Published in Cancer Weekly, February 8th, 2000
The use of molecular genetic methods for detection, role diagnostic markers, and prognostic indicators, as well as the molecular pathogenesis of soft tissue and bone tumors was studied recently by A. Slominski and colleagues at Loyola University Medical Center ("Molecular pathology of soft tissue and bone tumors -- A review," Archives of Pathology and Laboratory Medicine, 1999;123(12):1246-1259).
The researchers used studies containing chromosomal or genetic evaluation of bone and soft tissue tumors,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.